Osteoarthritis (OA) is the most common form of arthritis resulting in joint discomfort and
disability, culminating in decline in life quality. Attention has been drawn in recent years to …

Growing evidence has revealed the pivotal role of inflammatory biomarkers in the
pathogenesis of osteoarthritis. There is significant interest in the prognostic value of select …

Most these studies have examined the association of a biomarker with some aspect of the
natural history of osteoarthritis. As illustrated by the six studies reviewed here that included …

Arthritic diseases are a major cause of disability and morbidity, and cause an enormous
burden for health and social care systems globally. Osteoarthritis (OA) is the most common …

Biomarker combinations have the ability to subgroup the heterogenous osteoarthritis
population to allow a better scrutiny of diagnosis and treatment options. The application of …

Objective The aim of this narrative review is to summarize important findings from
biochemical marker studies relevant to osteoarthritis (OA) in the context of new discoveries …

Osteoarthritis (OA) is a disease of the whole joint organ, characterized by the loss of
cartilage, and structural changes in bone including the formation of osteophytes, causing …

Historically disease knowledge development and treatment innovation in osteoarthritis (OA)
has been considered to be slow. One of the many reasons purported as responsible for this …

Introduction Osteoarthritis (OA) affects over 500 million people worldwide. OA patients are
symptomatically treated, and current therapies exhibit marginal efficacy and frequently carry …

Objective The purpose of this overview of osteoarthritis (OA) biomarkers is to provide the
non-specialist with a toolbox, based on experience acquired by biomarker researchers over …